Holland Capital Invests in Curess
Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be achieved.
Systemic Family Support
Curess offers specialized ambulatory youth care (such as intensive systemic guidance, ambulatory emergency help, perspective research, and co-parenting investigations) and focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organization achieves this by applying self-developed software that supports core processes (such as planning) and thus reduces administrative pressure.
Strategic Parntership
With this strategic partnership, Curess has found a partner to achieve its ambitious strategic goals.
Eddy de Bruin, CEO of Curess, states: “With the support of Holland Capital, we can realize our ambitions and help even more young people and families. With their expertise and resources, we are better equipped to significantly increase our impact in youth care. We are committed to providing the necessary support to families to learn to live together better, without waiting lists, through our dedicated professionals.”
Margot Engels, Healthcare Partner at Holland Capital, adds: “We are proud to add Curess to our portfolio. Curess provides crucial support to families in an innovative way, and we look forward to working together on their growth ambitions and further professionalization of their services. Our shared vision is to provide the best possible care and support.”
About Curess
With over 200 registered professionals, Curess offers specialized ambulatory youth care to young people and families to ensure they can live together better. By utilizing personal and innovative methods, Curess strives for a safe and supportive environment for children and their families. Curess is active in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.
The participation in Curess fits within Holland Capital’s strategy to invest in companies that contribute to societal challenges and create value for society. With this investment, Holland Capital takes an important step in further strengthening its portfolio within the healthcare sector.
YOEP Onderwijs en Zorg bundelt krachten met Ad Astra
YOEP Onderwijs en Zorg bundelt krachten met Ad Astra Amsterdam, 14 maart 2022 – Onze deelneming YOEP Onderwijs en Zorg gaat samenwerken met Ad Astra begeleiding & behandeling, een jeugdzorgaanbieder die zich richt op de begeleiding en behandeling van kinderen en...
AMP Groep neemt bedrijfsactiviteiten over van Omega Logistics
Holland Capital sluit partnership met NL Cares Amsterdam, 21 april 2022 - Met veel plezier kondigen wij onze samenwerking met NL Cares aan, een vrijwilligersorganisatie die zichzelf als doel stelt om te bouwen aan een zorgzame samenleving. Met elkaar kunnen we impact...
Quantib has been acquired by RadNet
Quantib has been acquired by RadNet ROTTERDAM, January 24, 2022 – Our portfolio company Quantib has been acquired by RadNet, Inc. (NASDQ: RDNT), a US leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network...
Quantib has been acquired by RadNet
Quantib has been acquired by RadNet ROTTERDAM, January 24, 2022 – Our portfolio company Quantib has been acquired by RadNet, Inc. (NASDQ: RDNT), a US leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network...
Holland Capital realiseert succesvolle verkoop van Humeca aan i4hi
Holland Capital realiseert succesvolle verkoop van Humeca aan i4hi Borne / Amsterdam, 5 juli 2022 – Investeringsmaatschappij Holland Capital realiseert een succesvolle verkoop van Humeca aan collega-investeerder i4hi. Humeca is een toonaangevende leverancier van...
Eshgro trekt nieuwe investeerder aan voor verdere groei
Eshgro trekt nieuwe investeerder aan voor verdere groei Boxmeer/Blaricum, 31 augustus 2022 - Strikwerda Investments (SI) wordt de nieuwe meerderheidsaandeelhouder van IT-dienstverlener Eshgro uit Boxmeer en fuseert deze met haar portfoliobedrijf Total Specific Hosting...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl